Prevalence of canabinoides compound by urinalysis in men referred to Kerman clinical laboratories, a pilot study, 2003


Manzoumeh Shamsi Meimandi 1 , * , Kouros Divsalar 2 , Nozar Nakhaeai 3


1 Instructor, Department of Physiology & Pharmacology, Kerman University of Medical Sciences, Kerman, Iran.

2 Research Officer, Kerman University of Medical Sciences, Kerman, Iran.

3 Assistant professor, Departments of Community Medicine, Full professor, Pathology, Kerman University of Medical Sciences, Kerman, Iran.


Hormozgan Medical Journal: 9 (1); e90303
Published Online: April 20, 2005
Article Type: Research Article
Received: October 03, 2004
Accepted: April 20, 2005




Introduction: Hashish and canabinoides compounds are not only the most
illegally abused substances in the world but also have the most geographically
extensive territory. Because of high proportion of young population in Iran, its
neighborhood with Afghanistan and Pakistan, canabinoide abuse would be one of
the prominent problems of Iran in the future. So this primary study was
performed to determine the epidemiology of canabinoide compounds in Kerman.
Methods: In this descriptive study, Urine samples of 700 males, referred to a
clinical lab in Kerman city in 1382 were collected to determine canabinoid
metabolites. Assessment analysis was a monophasic immunoassay rapid
technique RSA (Rapid Situation Assessment). The study was completely
blind and only age and residence place (rural, urban) were defined. All
stages were confirmed and supervised by ethic committee.
Results: The prevalence of canabinoid use was 0.6 percent. All four positive
cases were urban, with ages 31, 36, 40 and 67. More than 90 percent of
those referred were urban with mean age of 46.8+16 while the mean age of
rural cases was 54.3+17 years.
Conclusion: Considering the age range and possibility underlying disease in
the study population, the prevalence of canabinoid use was more than
expected. But the urinalysis as method for assessing the prevalence requires
wide sample size in which the age distribution should match with study
population. In addition, the entrance criteria should not include sick cases.


Opioid Peptides – Urinalysis – Kerman – Laboratories

© 2005, Hormozgan Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. References are included in the PDF.